Nursing Edição Brasileira · Aug 27, 2026

Cutaneous Cellular Senescence: Inhibitors of Senolytics

By Lima HRM, Rocha JS, Braga LCUA

Cellular senescence is a fundamental biological process characterized by irreversible arrest of the cell proliferation cycle in response to various types of stress, such as DNA damage, oxidative stress, and telomere shortening. In the skin, the accumulation of senescent cells over time contributes not only to phenotypic aging, through extracellular matrix degradation, but also to the development of a chronic inflammatory microenvironment, known as the senescence-associated secretory phenotype (SASP). The use of senolytic drugs, capable of inducing selective apoptosis of these cells, has emerged as a promising strategy to rejuvenate tissues and prevent age-related diseases. This study aimed to conduct a systematic literature review on the molecular mechanisms of cutaneous senescence and the therapeutic potential of senolytic compounds in the Brazilian dermatological context. The methodology was based on a documentary bibliographic analysis, including molecular biology studies, reviews on cellular aging, and consensus statements on antiaging therapies published in the last decade. The results demonstrate that, although senolytic agents show efficacy in reducing the burden of senescent cells in experimental models and ex vivo tissues, clinical application in human dermatology still faces challenges related to selectivity, safety, and precise tissue delivery. It is concluded that inhibitors of senescent cells represent a new frontier for antiaging medicine, and that continued rigorous clinical research is essential to validate their efficacy and safety in reversing markers of cutaneous aging in the Brazilian population.

doi.org/10.36489/nursing.2026v32i340p20916-20919Open accessInterventions

AgingResearch.News